Shareholders' Equity (Tables)

9 Months Ended

Sep. 30, 2011

Shareholders' Equity

Share-Based Activity

	Three Months Ended				Nine Months Ended
	September 30,				September 30,
	2011		2010		2011		2010
Share-based compensation expense	$	1,591	$	885	$	4,762	$	3,425
Fair value of shares vested		227		242		2,589		2,809
Cash received from option exercises		132		141		4,760		683
Tax benefit from option exercises		26		12		489		81

Schedule Of Changes In Non-Vested Restricted Shares

			Weighted
		Number	Average
		of	Grant
		Shares	Price
Non-vested shares at December 31, 2010		664,909	$	22.16
	Shares granted	276,869		21.78
	Shares vested, net of shares repurchased to fund tax withholding requirements	(88,755)		22.57
	Shares forfeited	(248)		24.75
Non-vested shares at September 30, 2011		852,775	$	21.99

Schedule Of Stock Option Activity

					Weighted
					Average
			Weighted		Remaining
		Number	Average		Contractual
		of	Exercise		Term
		Shares	Price		(in years)
Outstanding at December 31, 2010		2,901,989	$	22.49	4.5
	Options exercised with total intrinsic value of $1,234,000	(244,125)		19.50
	Options terminated	(17,585)		25.42
Outstanding at September 30, 2011 with aggregate intrinsic value of $3,133,000		2,640,279	$	22.75	3.5
Vested or expected to vest at September 30, 2011 with aggregate intrinsic value
	of $3,133,000	2,640,279	$	22.75	3.5
Exercisable at September 30, 2011 with aggregate intrinsic value of $3,133,000		2,425,069	$	22.65	3.3

Schedule Of Reconciliation Of Numerator And Denominators Of Basic And Diluted Earnings Per Share

		Three Months Ended September 30,					Nine Months Ended September 30,
					Per					Per
		Earnings		Shares	Share		Earnings		Shares	Share
		(Numerator)		(Denominator)	Amount		(Numerator)		(Denominator)	Amount
2011:
Net earnings from continuing
	operations attributable to
	AmSurg Corp. per common
	share (basic)	$	13,069	30,436	$	0.43	$	37,502	30,424	$	1.23
Effect of dilutive securities
	options and non-vested shares		-	726				-	750
Net earnings from continuing
	operations attributable to
	AmSurg Corp. per common
	share (diluted)	$	13,069	31,162	$	0.42	$	37,502	31,174	$	1.20
Net earnings attributable
	to AmSurg Corp. per common	$	13,126	30,436	$	0.43	$	36,449	30,424	$	1.20
	share (basic)
Effect of dilutive securities
	options and non-vested shares		-	726				-	750
Net earnings attributable
	to AmSurg Corp. per common
	share (diluted)	$	13,126	31,162	$	0.42	$	36,449	31,174	$	1.17
2010:
Net earnings from continuing
	operations attributable to
	AmSurg Corp. per common
	share (basic)	$	12,844	30,251	$	0.42	$	37,961	30,234	$	1.26
Effect of dilutive securities
	options and non-vested shares		-	369				-	430
Net earnings from continuing
	operations attributable to
	AmSurg Corp. per common
	share (diluted)	$	12,844	30,620	$	0.42	$	37,961	30,664	$	1.24
Net earnings attributable
	to AmSurg Corp. per common	$	13,118	30,251	$	0.42	$	38,957	30,234	$	1.29
	share (basic)
Effect of dilutive securities
	options and non-vested shares		-	369				-	430
Net earnings attributable
	to AmSurg Corp. per common
	share (diluted)	$	13,118	30,620	$	0.43	$	38,957	30,664	$	1.27